Pershing Square Holdings, Ltd. Sends Communication to Investors Regarding Developments at Valeant Pharmaceuticals International, Inc.

AMSTERDAM--()--Regulatory News:

Pershing Square Holdings, Ltd. today released an email to investors. The text of the email is set forth below:

Dear Pershing Square Investor,

Today, Valeant Pharmaceuticals International, Inc. issued a press release announcing that the Board has appointed Joseph C. Papa as Chairman and CEO of Valeant. Please find a link to Valeant’s press release here: http://ir.valeant.com/news-releases/2016/04-25-2016-133930304

Kind regards,
Pershing Square IR
ir@persq.com

About Pershing Square Holdings, Ltd.

Pershing Square Holdings, Ltd. (PSH:NA) is an investment holding company structured as a closed end fund that makes concentrated investments principally in North American companies.

Contacts

MEDIA
Maitland
James Devas, +44 20 7379 5151
Media-pershingsquareholdings@maitland.co.uk

Contacts

MEDIA
Maitland
James Devas, +44 20 7379 5151
Media-pershingsquareholdings@maitland.co.uk